Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2003
03/05/2003EP1287005A2 Benzoic acid esters having antiplasmid effect
03/05/2003EP1287003A1 Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil
03/05/2003EP1286998A1 Oxazolidinone derivatives with antibiotic activity
03/05/2003EP1286994A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286986A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
03/05/2003EP1286974A2 Medicament for viral diseases
03/05/2003EP1286964A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
03/05/2003EP1286954A2 7-substituted fused ring tetracycline compounds
03/05/2003EP1286703A2 Methods and compounds for controlled release of recombinant parvovirus vectors
03/05/2003EP1286700A2 Tumor activated prodrug compounds
03/05/2003EP1286696A1 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof
03/05/2003EP1286694A2 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286691A2 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
03/05/2003EP1286690A2 Use of alpha-msh and epo for preventing or treating ischemic conditions
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP1286661A2 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
03/05/2003EP1194427B1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv
03/05/2003EP1169316B1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
03/05/2003EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/05/2003EP1079826B1 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
03/05/2003EP1062214B1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels
03/05/2003EP0942901B1 Cyclic imines as pesticides
03/05/2003EP0920527A4 SYNTHESIS OF beta-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE
03/05/2003EP0912526B1 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0869807B1 Use of a medicament and use of mixture of substances to produce a medicament
03/05/2003EP0831830B1 Imidazole compounds
03/05/2003EP0801067B1 Novel quinuclidine derivatives and medicinal composition thereof
03/05/2003EP0792273B1 Bicyclic oxazine and thiazine oxazolidinone antibacterials
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0656952B1 Cationic peptides and method for production
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
03/05/2003CN1400910A Factor VII or VIIa like molecules
03/05/2003CN1400909A Pharmaceutical composition
03/05/2003CN1400907A 9M-negative EHV-mutants
03/05/2003CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/05/2003CN1400871A Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability of undesired permeability of the
03/05/2003CN1400220A Two kinds of cDNA with activity capable of extensively inhibiting HIV and its expression, separation and purification method in protokaryon
03/05/2003CN1400006A Zedoary oil capsule for resisting virus
03/05/2003CN1400003A Medicine composition for curing hepatitis
03/05/2003CN1400000A External Chinese medicine adhesive plaster for curing appendicitis and its preparation method
03/05/2003CN1399991A Cell protection preparation for preventing HIV infection
03/05/2003CN1399978A Chinese medicine liquor for curing pointed condyloma
03/05/2003CN1399972A Medicine for curing chicken disease
03/05/2003CN1399963A Diammonium glycyrrhizanate transfusion preparation
03/05/2003CN1399957A Application of shikonin and its derivative in pharmaceutical industry
03/05/2003CN1399895A Spanish needles concentrated liquid tea
03/05/2003CN1102595C Penems and their derivatives
03/05/2003CN1102592C 2R, 4S, S,S-and 2S, 4R, S,S-hydroxyitraconazole
03/05/2003CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid
03/05/2003CN1102410C Mupirocin calcium salt emulsifiable paste composition
03/05/2003CN1102409C Triple live chicken vaccine and its production process
03/05/2003CA2421283A1 Novel mmp-2 derivatives for use as inhibitors of integrin .alpha.v.beta.3
03/04/2003US6528655 Aromatic derivatives with HIV integrase inhibitory properties
03/04/2003US6528628 Making 6-O-alkyl erythromycin A or its oxime starting from the novel intermediate erythromycin A 9-oxime
03/04/2003US6528626 Viral library for use in the diagnosis and treatment of viral diseases
03/04/2003US6528623 Antibodies that specifically bind ACT-4-L-h-1 ligand
03/04/2003US6528515 Beta-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (beta -FTC) and penciclovir
03/04/2003US6528513 Viricides; especially cytomegalo virus
03/04/2003US6528510 HIV protease inhibitors
03/04/2003US6528509 Pyrazole compositions useful as inhibitors of ERK
03/04/2003US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli
03/04/2003US6528495 Aryl phosphate derivatives of d4T having anti-HIV activity
03/04/2003US6528269 Monoclonal antibodies; can be used to diagnose neurodegenerative disorders
03/04/2003US6528250 Administering multiple low doses of the virus using intravenous route
03/04/2003US6528065 Attenuated dengue-3 virus vaccine
03/04/2003US6528064 Recombinant trytophan mutants of influenza
03/04/2003US6528056 Inhibition of viral infection using antigen-binding proteins
03/04/2003US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases
03/04/2003US6528048 Ophthalmic solutions
03/04/2003CA1341423C Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
03/03/2003WO2002020496A1 2-guanidino-4-aryl-quinazoline
03/03/2003CA2421222A1 2-guanidino-4-aryl-quinazoline
02/2003
02/27/2003WO2003016915A1 Tumor specific oligosaccharide sequences and use thereof
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016511A1 Method of extended culture for antigen-specific cytotoxic t lumphocytes
02/27/2003WO2003016472A2 Hybrid interferon/interferon tau proteins, compositions and methods of use
02/27/2003WO2003016468A2 Antagonistic anti-htnfsf13b human antibodies
02/27/2003WO2003016339A1 A frog skin antibacterial peptide derivative
02/27/2003WO2003016337A1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope
02/27/2003WO2003016333A2 Virus coat protein/receptor chimeras and methods of use
02/27/2003WO2003016315A1 Sodium salt of an hiv integrase inhibitor
02/27/2003WO2003016312A1 Process for preparation of carbapenem antibiotics
02/27/2003WO2003016306A1 Hiv inhibiting pyrimidines derivatives
02/27/2003WO2003016291A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ
02/27/2003WO2003016277A1 Cyclohept`b!indole derivatives as spla2 inhibitors
02/27/2003WO2003016275A1 Antiviral agent
02/27/2003WO2003016273A2 Peptide arginals and methods for treating disseminated intravascular coagulation
02/27/2003WO2003016269A1 5-amidino-n-(2-aminophenethyl)-n-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor
02/27/2003WO2003015831A1 Gas microsphere liposome composites
02/27/2003WO2003015819A1 Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b
02/27/2003WO2003015816A1 Immunomodulatory oligonucleotide formulations and methods for use thereof
02/27/2003WO2003015814A1 New peptides and use thereof in therapeutic agents against feline fiv infection
02/27/2003WO2003015809A2 Antimicrobial cationic peptides and formulations thereof
02/27/2003WO2003015806A1 Composition for the prophylaxis and treatment of infective immunologic disorders
02/27/2003WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
02/27/2003WO2003015798A1 Novel virus proliferation inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
02/27/2003WO2003015797A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
1 ... 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 ... 1798